beREADY® – an advanced molecular tool to evaluate endometrium and its readiness for embryo implantation
beREADY test is part of personalized medicine and will let you know, when is the optimal time for embryo implantation for a specific patient. The test, done in our clinic, bases on patented TAC-Seq technology and indicates whether the endometrium has a receptive molecular profile at the time when it is expected to be perfectly matured and ready for embryo implantation.
Woman’s physiology and drug response curve are very individual, as are the causes of infertility. About 30% of patients need significantly different time of embryo implantation compared to an average standard time of all patients. Inadequate timing on embryo transfer is one of the reasons for infertility treatment failure.
beREADY test, otherwise known as the embryo implantation test, is developed for improving the results of infertility treatments i.e meant for patients, who want to be sure of the success of the treatment, decreasing the risk of infertility treatment failure. A biopsy will be taken from uterine lining during a cycle prior implantation. Tissue samples will be sent to laboratory, where clinically significant biomarkers, which identify the receptivness of endometrium, will be determined. BeREADY test will identify the most significant biomarker-gene activity (gene expression) in the tissue being studied and will give an evaluation of endometrium readiness.
beREADY test is implemented in Fertility Clinic Nordic in cooperation with The Competence Centre on Health Technologies.